北京万东医疗科技股份有限公司关于以集中竞价交易方式首次回购股份的公告

Group 1 - The company has approved a share repurchase plan using its own funds, with a total amount ranging from RMB 30 million to 60 million, and a maximum repurchase price of RMB 25 per share, to be executed within 12 months [1] Group 2 - As of September 25, 2025, the company has repurchased 281,200 shares, representing 0.04% of the total share capital, with a total expenditure of RMB 4,998,291, excluding transaction fees [2] Group 3 - The company will continue to make repurchase decisions based on market conditions and will fulfill its information disclosure obligations regarding the progress of the share repurchase [3]